Long intergenic non-protein coding RNA 2882 (LINC02882)

Long intergenic non-protein coding RNA 2882 (LINC02882) is a member of the long intergenic non-coding RNA (lincRNA) class, which comprises RNA transcripts longer than 200 nucleotides that do not overlap protein-coding regions and are generally not translated into proteins[1][3][7]. LINC02882 is annotated in genetic databases as a non-coding RNA and is affiliated with the lncRNA family[1][3]. LincRNAs—including LINC02882—are implicated in various regulatory functions, such as remodeling chromatin, stabilizing RNAs, modulating protein activity, regulating transcription, and exerting enhancer-like effects; their gene regulatory mechanisms can be both sequence-dependent and sequence-independent[5][7]. While the specific function and disease role of LINC02882 remain poorly characterized, the general class is associated with fine-tuning gene expression and has emerging links to pathologies such as cancer[5]. LINC02882 has been detected among EZH2-interacting non-coding RNAs in multiple myeloma cells, which may suggest involvement in epigenetic regulation, though direct disease associations and therapeutic targeting have not been established[6]. No drugs or established therapeutic mechanisms currently target LINC02882, and it is not considered a traditional metabolic, enzymatic, transporter, or receptor target[1][3][6].

Other names

RP11-81H3.2LINC02882